Clinical Trials Insight: 700034361

Trial Profile

Clinical Trials Insight: 700034361

Phase of Trial: Phase I

Latest Information Update: 10 Jun 2008

At a glance

  • Drugs Rhenium 188 P 2045 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Bayer HealthCare Pharmaceuticals
  • Most Recent Events

    • 10 Jun 2008 New trial record.
    • 03 Jun 2008 Upated results presented at ASCO 2008.
    • 03 Jun 2007 Results were presented at ASCO in June 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top